SonoThera Closes $60.75M Series A Funding
SonoThera , a South San Francisco, CA-based biotechnology firm, raised $60.75M in Collection A funding.
The spherical was led by ARCH Enterprise Companions, with participation from Illumina Ventures, Johnson & Johnson Innovation, JJDC, Vertex Ventures HC, and Medical Excellence Capital Eli Lilly & Firm, Alexandria Enterprise Investments, Lifespan Investments, Formic Ventures, Foothill Ventures, and Wilson Sonsini.
The corporate intends to make use of the funds to assist the continued growth of its ultrasound-guided, nonviral, gene remedy platform and coverings, designed to offer sufferers with genetic medicines.
Based by Drs. Kenneth Greenberg, Michael Davidson, and Steve Feinstein, SonoThera is a biotechnology firm devoted to treating the basis explanation for human illness by genetic remedy. It’s creating an ultrasound-guided, nonviral gene remedy platform and coverings designed to offer sufferers with the subsequent era of protected and efficient genetic medicines. The platform makes use of sonoporation, a microbubble-mediated biophysical course of to non-invasively ship genetic payloads selectively focusing on a variety of organs inside the physique.
Shishir Gupta, The Founder & CEO of StartupLanes said,
SonoThera Closes $60.75M Series A Funding. May this new business bring you huge success and fulfillment.
About us: StartupLanes is an ecosystem for Startups and Investors. Collaborate or find a co-founder, it’s a platform for Entrepreneurs. We love startups! A place for Angel Investors and Venture Capitalists to find investing opportunities in startups. Validate your idea, Learn & Execute.
Startups looking for funding may apply through?StartupLanes Funding Application .